Director dealings: Astrazeneca CEO raises stake
By Iain Gilbert
Date: Friday 18 Sep 2026
(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.
Soriot, who took over as CEO in October 2012, purchased the shares at an average price of 12,102p each, for a total value of £7.26m.
As of 1540 BST, Astrazeneca shares were up 0.82% at 12,530p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Astrazeneca (AZN)
Director name: Soriot,Pascal
Amount purchased: 60,000 @ 12,102.00p
Value: £7,261,199.80
Trustpilot Group (TRST)
Director name: Roy ,Marcus
Amount purchased: 45,436 @ 218.98p
Value: £99,493.93
Trustpilot Group (TRST)
Director name: Byng-Thorne,Zillah
Amount purchased: 27,746 @ 215.14p
Value: £59,692.75
Trustpilot Group (TRST)
Director name: Byng-Thorne,Zillah
Amount purchased: 17,854 @ 222.87p
Value: £39,791.21
Tmt Investments (TMT)
Director name: Selegenev,Alexander
Amount purchased: 10,000 @ $3.23
Value: $32,300.00
Tmt Investments (TMT)
Director name: Selegenev,Alexander
Amount purchased: 3,000 @ $3.46
Value: $10,380.00
Domino's Pizza Group (DOM)
Director name: Perriss,Robyn
Amount purchased: 4,850 @ 204.50p
Value: £9,918.40
Top Director Sells
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN